Clinical Trial Update: Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED) [Phase 2]

View source ↗

Summary

This is an update on a completed Phase 2 trial of vicriviroc in treatment-experienced HIV-infected subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Vicriviroc (MK-7690)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections, Acquired Immunodeficiency Syndrome | Phase 2 | Status: COMPLETED